Cyclin D1 genotype and expression in sporadic hemangioblastomas.

作者: Johanna M. M. Gijtenbeek , Sandra H. E. Boots-Sprenger , Barbara Franke , Pieter Wesseling , Judith W. M. Jeuken

DOI: 10.1007/S11060-004-7326-Z

关键词:

摘要: Central nervous system (CNS) hemangioblastomas are highly-vascularized tumors occurring in sporadic form or as a manifestation of von Hippel–Lindau disease (VHL). The VHL protein (pVHL) regulates various target genes, one which is the CCND1 gene, encoding cyclin D1, that plays critical role control cell cycle. Overexpression D1 found many cancers. gene contains common G → A polymorphism (870G > A) enhances alternative splicing gene. genotype associated with clinical outcome number cancers although prognostic significance varies tumor type. In disease, has been suggested genetic modifier influences susceptibility to hemangioblastomas.

参考文章(21)
H. J. Altermatt, N. Thatcher, J. Heighway, W. D. J. Ryder, D. C. Betticher, P. Hoban, Alternate splicing produces a novel cyclin D1 transcript. Oncogene. ,vol. 11, pp. 1005- 1011 ,(1995)
H. Luginbühl, J. T. McGrath, R. Fankhauser, Tumours of the nervous system. Bulletin of The World Health Organization. ,vol. 50, pp. 53- 69 ,(1974)
Eamonn R Maher, Steven C Clifford, Nancy Fernandes da Silva, Frances M Richards, Mark R Morris, Farida Latif, Malgorzata Zatyka, Kai-Uwe Eckardt, Michael S Wiesener, Richard S Houlston, Identification of Cyclin D1 and Other Novel Targets for the von Hippel-Lindau Tumor Suppressor Gene by Expression Array Analysis and Investigation of Cyclin D1 Genotype as a Modifier in von Hippel-Lindau Disease Cancer Research. ,vol. 62, pp. 3803- 3811 ,(2002)
Tracey A. Holland, Jackie Elder, Jonathan M. McCloud, Christine Hall, Mark Deakin, Anthony A. Fryer, James B. Elder, Paul R. Hoban, Subcellular localisation of cyclin D1 protein in colorectal tumours is associated with p21WAF1/CIP1 expression and correlates with patient survival International Journal of Cancer. ,vol. 95, pp. 302- 306 ,(2001) , 10.1002/1097-0215(20010920)95:5<302::AID-IJC1052>3.0.CO;2-#
Charles C Wykoff, Christopher W Pugh, Patrick H Maxwell, Adrian L Harris, Peter J Ratcliffe, Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling. Oncogene. ,vol. 19, pp. 6297- 6305 ,(2000) , 10.1038/SJ.ONC.1204012
Timothy R Porter, Frances M Richards, Richard S Houlston, D Gareth R Evans, Janusz A Jankowski, Fiona Macdonald, Gail Norbury, Stewart J Payne, Samantha A Fisher, Ian Tomlinson, Eamonn R Maher, None, Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer. Oncogene. ,vol. 21, pp. 1928- 1933 ,(2002) , 10.1038/SJ.ONC.1205245
Moneeb Ehtesham, Peter Kabos, William H Yong, Wouter I Schievink, Keith L Black, John S Yu, Development of an intracranial ependymoma at the site of a pre-existing cavernous malformation. Surgical Neurology. ,vol. 60, pp. 80- 82 ,(2003) , 10.1016/S0090-3019(03)00032-6
O. Iliopoulos, A. P. Levy, C. Jiang, W. G. Kaelin, M. A. Goldberg, Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein Proceedings of the National Academy of Sciences of the United States of America. ,vol. 93, pp. 10595- 10599 ,(1996) , 10.1073/PNAS.93.20.10595
Lizhong Wang, Tomonori Habuchi, Kenji Mitsumori, Zhenhua Li, Toshiyuki Kamoto, Hidefumi Kinoshita, Norihiko Tsuchiya, Kazunari Sato, Chikara Ohyama, Akira Nakamura, Osamu Ogawa, Tetsuro Kato, Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism. International Journal of Cancer. ,vol. 103, pp. 116- 120 ,(2003) , 10.1002/IJC.10793
Sarah L. Holley, Gary Parkes, Christoph Matthias, Ulrike Bockmühl, Volker Jahnke, Korinna Leder, Richard C. Strange, Anthony A. Fryer, Paul R. Hoban, Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck. American Journal of Pathology. ,vol. 159, pp. 1917- 1924 ,(2001) , 10.1016/S0002-9440(10)63038-6